Acurx Pharmaceuticals LLC Ordinary Shares ACXP 深 沪
已收盘 12-05 16:00:00 美东时间
3.21
-0.270
-7.76%
华盛通- 最 高3.44
- 今 开3.42
- 成交量 4.99万股
- 最 低 3.195
- 昨 收 3.48
- 总市值 493.76万
- 52周最高 25.00
- 市盈率 静 --
- 换手率 3.25%
- 52周最低 3.1713
- 委 比 76.88%
- 总股本 153.82万
- 历史最高 176.40
- 量 比 1.30
- 振 幅 7.04%
- 历史最低 3.195
- 每 手 1
- 风险率 4.41%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多New to The Street Show #702 Airs Today on Bloomberg at 6:30 PM EST
The show airs as sponsored programming with TV commercials by Synergy CHC, Sust...
11-23 00:20
Acurx Pharmaceuticals Q3 EPS $(1.23) Beats $(1.31) Estimate
Acurx Pharmaceuticals (NASDAQ:ACXP) reported quarterly losses of $(1.23) per share which beat the analyst consensus estimate of $(1.31) by 6.11 percent. This is a 64.35 percent increase over losses of $(3.45) per share
11-12 20:02
Earnings Scheduled For November 12, 2025
Companies Reporting Before The Bell • Hudbay Minerals (NYSE:HBM) is projected t...
11-12 19:11
Acurx Pharmaceuticals Presents Data On Ibezapolstat Clinical Study Program At Diseases Society of America In Atlanta
Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), is a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections. It announced today
10-28 20:19
Acurx Pharma Secures Australian Patent For DNA Polymerase IIIC Inhibitors, Expanding ACX-375C Coverage Across Five Countries
Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule
10-09 19:35
12 Health Care Stocks Moving In Wednesday's Intraday Session
Gainers Xenetic Biosciences (NASDAQ:XBIO) stock moved upwards by 137.1% to $10...
10-09 01:06
Why Confluent Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Shares of Confluent Inc (NASDAQ:CFLT) rose sharply in pre-market trading. Confl...
10-08 16:43
美股大行评级 | 潜在涨幅超31%！摩根大通维持通用汽车"超配"评级，目标价从60美元升至80美元
今日重点评级关注：Maxim Group：上调Adial Pharmaceuticals评级至"买入"，目标价1.5美元；BTIG：维持Climb Bio"买入"评级，目标价从7美元升至8美元
10-01 20:13
Acurx Pharma Receives Favorable Opinion From PDCO Of EMA On Acurx's Pediatric Investigation Plan For Ibezapolstat Use In Children With C. Difficile Infection
The Paediatric Committee (PDCO) of the European Medicines Agency issued a positive opinion on Acurx's Pediatric Investigation Plan (PIP) for ibezapolstat use in children with C. difficile infectionReceipt of this
09-30 19:34
Acurx Pharmaceuticals Increases Authorized Common Stock Shares
Acurx Pharmaceuticals ( ($ACXP) ) just unveiled an update. On September 16, 202...
09-23 04:57
